Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Missed Dose Effect of Irbesartan in Hypertension
NCT00265967Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of irbesartan in hypertension (HTN), sponsored by Sanofi. Primary endpoints: Changes in 24 hours mean ambulatory blood pressure on the missing dose day and Frequency, severity, seriousness of adverse events emerging during the treatment. Started Sep 2005; status: completed.
02
Drugs
irbesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00265967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265967.